Annual CFI
N/A
31 December 2023
Summary:
Akari Therapeutics annual cash flow from investing activities is not available.AKTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
01 September 2024
Summary:
Akari Therapeutics quarterly cash flow from investing activities is not available.AKTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
01 September 2024
Summary:
Akari Therapeutics TTM cash flow from investing activities is not available.AKTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AKTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Akari Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | - | $379.10 K(-200.0%) | $0.00(-100.0%) |
| Sept 2018 | - | -$379.10 K(<-9900.0%) | -$379.10 K(-103.8%) |
| Dec 2017 | $9.99 M(-199.2%) | $0.00(0.0%) | $9.99 M(-77.8%) |
| Sept 2017 | - | $0.00(-100.0%) | $45.07 M(-2.2%) |
| June 2017 | - | $9.99 M(<-9900.0%) | $46.09 M(-559.5%) |
| Mar 2017 | - | -$5600.00(-100.0%) | -$10.03 M(-0.4%) |
| Dec 2016 | -$10.07 M(-823.3%) | $35.08 M(+3342.8%) | -$10.07 M(-77.7%) |
| Sept 2016 | - | $1.02 M(-102.2%) | -$45.17 M(+0.9%) |
| June 2016 | - | -$46.13 M(>+9900.0%) | -$44.78 M(-3417.5%) |
| Mar 2016 | - | -$42.10 K(+123.9%) | $1.35 M(-3.0%) |
| Dec 2015 | $1.39 M | -$18.80 K(-101.3%) | $1.39 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $1.41 M(>+9900.0%) | $1.41 M(+893.4%) |
| June 2015 | - | $0.00(0.0%) | $142.00 K(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2014 | - | $142.00 K(-200.0%) | $0.00(-100.0%) |
| June 2014 | - | -$142.00 K(<-9900.0%) | -$142.00 K(<-9900.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $0.00(0.0%) | - | - |
| Dec 2012 | $0.00(0.0%) | - | - |
| Dec 2011 | $0.00(0.0%) | - | - |
| Dec 2010 | $0.00 | - | - |
FAQ
- What is the all time high annual CFI for Akari Therapeutics?
- What is the all time high quarterly CFI for Akari Therapeutics?
- What is the all time high TTM CFI for Akari Therapeutics?
What is the all time high annual CFI for Akari Therapeutics?
Akari Therapeutics all-time high annual cash flow from investing activities is $9.99 M
What is the all time high quarterly CFI for Akari Therapeutics?
Akari Therapeutics all-time high quarterly cash flow from investing activities is $35.08 M
What is the all time high TTM CFI for Akari Therapeutics?
Akari Therapeutics all-time high TTM cash flow from investing activities is $46.09 M